These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23512607)

  • 61. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accumulating evidence for a role of oxidized phospholipids in infectious diseases.
    Matt U; Sharif O; Martins R; Knapp S
    Cell Mol Life Sci; 2015 Mar; 72(6):1059-71. PubMed ID: 25410378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.
    Navab M; Reddy ST; Van Lenten BJ; Buga GM; Hough G; Wagner AC; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2553-60. PubMed ID: 23077141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxidized phospholipids: from molecular properties to disease.
    Fruhwirth GO; Loidl A; Hermetter A
    Biochim Biophys Acta; 2007 Jul; 1772(7):718-36. PubMed ID: 17570293
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Physiological redox signalling and regulation of ion channels: implications for pulmonary hypertension.
    Ward JPT
    Exp Physiol; 2017 Sep; 102(9):1078-1082. PubMed ID: 28004868
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.
    Furnkranz A; Leitinger N
    Curr Pharm Des; 2004; 10(8):915-21. PubMed ID: 15032694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxidized phospholipids as modulators of inflammation in atherosclerosis.
    Leitinger N
    Curr Opin Lipidol; 2003 Oct; 14(5):421-30. PubMed ID: 14501580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.
    Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S
    Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dooming Phagocyte Responses: Inflammatory Effects of Endogenous Oxidized Phospholipids.
    Di Gioia M; Zanoni I
    Front Endocrinol (Lausanne); 2021; 12():626842. PubMed ID: 33790857
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The innate immune response to products of phospholipid peroxidation.
    Weismann D; Binder CJ
    Biochim Biophys Acta; 2012 Oct; 1818(10):2465-75. PubMed ID: 22305963
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stereospecific and redox-sensitive increase in monocyte adhesion to endothelial cells by homocysteine.
    Postea O; Krotz F; Henger A; Keller C; Weiss N
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):508-13. PubMed ID: 16373615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD44 Loss Disrupts Lung Lipid Surfactant Homeostasis and Exacerbates Oxidized Lipid-Induced Lung Inflammation.
    Dong Y; Arif AA; Guo J; Ha Z; Lee-Sayer SSM; Poon GFT; Dosanjh M; Roskelley CD; Huan T; Johnson P
    Front Immunol; 2020; 11():29. PubMed ID: 32082314
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Free radicals and lipid signaling in endothelial cells.
    O'Donnell VB
    Antioxid Redox Signal; 2003 Apr; 5(2):195-203. PubMed ID: 12716479
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apoptotic Bax at Oxidatively Stressed Mitochondrial Membranes: Lipid Dynamics and Permeabilization.
    Dingeldein APG; Pokorná Š; Lidman M; Sparrman T; Šachl R; Hof M; Gröbner G
    Biophys J; 2017 May; 112(10):2147-2158. PubMed ID: 28538152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxidized phospholipid signaling in traumatic brain injury.
    Anthonymuthu TS; Kenny EM; Lamade AM; Kagan VE; Bayır H
    Free Radic Biol Med; 2018 Aug; 124():493-503. PubMed ID: 29964171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
    de Assis EF; Silva AR; Caiado LF; Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM; Bozza PT; de Castro-Faria-Neto HC
    J Immunol; 2003 Aug; 171(4):2090-8. PubMed ID: 12902515
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system.
    Mohiuddin I; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
    J Surg Res; 2006 Jun; 133(2):143-9. PubMed ID: 16360172
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oxidised phospholipids as biomarkers in human disease.
    Philippova M; Resink T; Erne P; Bochkov V
    Swiss Med Wkly; 2014; 144():w14037. PubMed ID: 25539162
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Smoking, metalloproteinases, and vascular disease.
    Perlstein TS; Lee RT
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):250-6. PubMed ID: 16339501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.